Johnson & Johnson Market Cap

Johnson & Johnson has a market cap or net worth of $640.75 billion as of November 3, 2026. It is the 21st most valuable company in the world and the 17th biggest in the United States. Its market cap has increased by 40.81% in one year.

Market Cap

640.75B

Enterprise Value

668.18B

1-Year Change

40.81%

Global Rank

#21

Country Rank

#17 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Johnson & Johnson's market cap has increased from $108.92B to $640.75B, an increase of 488.29%. That is a compound annual growth rate of 6.55%.

Market Cap History

Date	Market Cap	% Change
Nov 3, 2026	640.75B	28.51%
Dec 31, 2025	498.60B	43.20%
Dec 31, 2024	348.19B	-7.72%
Dec 29, 2023	377.32B	-18.30%
Dec 30, 2022	461.85B	2.55%
Dec 31, 2021	450.36B	8.70%
Dec 31, 2020	414.31B	7.92%
Dec 31, 2019	383.91B	10.92%
Dec 31, 2018	346.11B	-7.79%
Dec 29, 2017	375.36B	19.76%
Dec 30, 2016	313.43B	10.28%
Dec 31, 2015	284.22B	-2.90%
Dec 31, 2014	292.70B	13.27%
Dec 31, 2013	258.42B	33.02%
Dec 31, 2012	194.27B	8.47%
Dec 30, 2011	179.09B	5.44%
Dec 31, 2010	169.86B	-4.42%
Dec 31, 2009	177.71B	7.05%
Dec 31, 2008	166.00B	-13.03%
Dec 31, 2007	190.88B	-0.28%
Dec 29, 2006	191.42B	7.06%
Dec 30, 2005	178.79B	-5.00%
Dec 31, 2004	188.21B	22.75%
Dec 31, 2003	153.33B	-3.90%
Dec 31, 2002	159.55B	-11.43%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Eli Lilly and Company	1.26T
AbbVie	521.11B
Merck & Co.	368.89B
Novartis AG	306.70B
AstraZeneca	290.07B
Amgen	251.94B
Gilead Sciences	211.70B
Novo Nordisk	175.43B

Market Cap Rankings